Los Angeles Capital Management’s Acceleron Pharma XLRN Stock Holding History

Los Angeles Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,320	Closed	-$1.02M	–	1537
2020 Q1	$1.02M	Buy	11,320 +200	+2%	+$15.5K	0.01%	705
2019 Q4	$590K	Sell	11,120 -2,180	-16%	-$99.4K	﹤0.01%	980
2019 Q3	$525K	Sell	13,300 -5	-0%	-$217	﹤0.01%	975
2019 Q2	$547K	Sell	13,305 -3,425	-20%	-$142K	﹤0.01%	1015
2019 Q1	$779K	Buy	+16,730	New	+$735K	﹤0.01%	943
2018 Q4	–	Sell	-15,080	Closed	-$863K	–	1428
2018 Q3	$863K	Sell	15,080 -2,440	-14%	-$120K	﹤0.01%	921
2018 Q2	$850K	Buy	+17,520	New	+$638K	﹤0.01%	962

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Los Angeles Capital Management's XLRN Position: Q2 2020 in Review

Los Angeles Capital Management sold out of Acceleron Pharma (XLRN) in Q2 2020, closing a stake of 11,320 shares — an estimated $1.02M sold.

Los Angeles Capital Management first reported a position in XLRN in Q2 2018 and held it in 7 quarters. The position peaked at $1.02M in Q1 2020. 242 funds tracked by Wall St. Rank hold XLRN as of Q2 2020.

Los Angeles Capital Management reported no remaining Acceleron Pharma position as of Q2 2020 after selling out during the quarter.
Los Angeles Capital Management sold 11,320 Acceleron Pharma shares in Q2 2020, an estimated $1.02M.
Los Angeles Capital Management first reported a position in Acceleron Pharma in Q2 2018 and held it in 7 quarters.
Los Angeles Capital Management's Acceleron Pharma position peaked at $1.02M in Q1 2020.
242 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2020.

Based on Los Angeles Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.